Damora Therapeutics (DMRA) Restructuring Costs (2023 - 2024)
Damora Therapeutics (DMRA) posted Restructuring Costs of $968,000 for FY2024, down 71.9% from $3.45 million in FY2023.
Powered by 
Analysis
Damora Therapeutics (DMRA) Restructuring Costs (2023 - 2024) Analysis & Trends
- Business Quant data shows DMRA's Restructuring Costs at $3.45 million in FY2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,133.90 Bn | 1,102.48 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 616.46 Bn | 534.99 Bn | 17.26 Bn |
| 3 | AbbVie | 501.26 Bn | 474.37 Bn | 12.70 Bn |
| 4 | Merck | 367.00 Bn | 321.38 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.91 Bn | 261.90 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.33 Bn | 235.02 Bn | 12.86 Bn |
| 7 | Amgen | 235.82 Bn | 191.22 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 190.63 Bn | 164.82 Bn | 6.22 Bn |
| 9 | Pfizer | 169.35 Bn | 115.99 Bn | 10.94 Bn |
| 10 | Damora Therapeutics | 1.33 Bn | -10.48 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 968,000.00 |
| Dec 31, 2023 | 720,000.00 |
| Sep 30, 2023 | 2.73 Mn |
API Access
Damora Therapeutics Restructuring Costs API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=restructuring-costs&ticker=DMRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "restructuring-costs", "ticker": "DMRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=restructuring-costs&ticker=DMRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();